CeQur is a series c plus startup. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
CeQur develops and commercializes simple-to-use insulin delivery systems that empower people living with diabetes. Its simple, three-day, wearable devices provide discreet and convenient insulin delivery.
Stage
series-c-plus
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky